Investigating crystal engineering principles using a data set of 50 pharmaceutical cocrystals

Similar documents
Validation of Experimental Crystal Structures

Applications of the CSD to Structure Determination from Powder Data

Crystal Engineering Strategies: Design of new Synthons and Enhancement of API s Solubility

Nitrile Groups as Hydrogen-Bond Acceptors in a Donor-Rich Hydrogen-Bonding Network. Supplementary Information

Hydrogen bonding in oxalic acid and its complexes: A database study of neutron structures

Supramolecular heterosynthons and their role in cocrystal design

Crystal structure of DL-Tryptophan at 173K

Exploring symmetry related bias in conformational data from the Cambridge Structural Database: A rare phenomenon?

CAMBRIDGE STRUCTURAL DATABASE SYSTEM 2010 RELEASE WORKED EXAMPLES

Screening for cocrystals of succinic acid and 4-aminobenzoic acid. Supplementary Information

Experiment and Theory in the study of Intermolecular Interactions

Dr Mingzhong Li School of Pharmacy, De Montfort University

Chapter 4. Glutamic Acid in Solution - Correlations

CSD. Unlock value from crystal structure information in the CSD

Electronic Supplementary Information (ESI)

Intermolecular Forces I

CSD. CSD-Enterprise. Access the CSD and ALL CCDC application software

Paper No. 1: ORGANIC CHEMISTRY- I (Nature of Bonding and Stereochemistry)

(+-)-3-Carboxy-2-(imidazol-3-ium-1-yl)- propanoate

Pharmaceutical co-crystals of diflunisal and. diclofenac with theophylline

Probing Hydrogen Bond Energies by Mass Spectrometry

Elements and the Periodic Table

Hydrogen Bonding & Molecular Design Peter

Structural Characterization and Rationalization of Formation, Stability, and Transformations of Benperidol Solvates

Electronic Supporting Information (ESI)

Molecular Aggregation

Increase in Solubility of Poorly-Ionizable Pharmaceuticals by Salt Formation. A Case of Agomelatine Sulfonates.

Supporting information. for. isatins and α-amino acids

Critical Temperature - the temperature above which the liquid state of a substance no longer exists regardless of the pressure.

Syntheses and Pharmacokinetics Properties of an Iloperidone. Pharmaceutical Cocrystal

Protein Structure. W. M. Grogan, Ph.D. OBJECTIVES

Crystallisation and physicochemical property characterisation of conformationally-locked co-crystals of fenamic acid derivatives

Solutions and Non-Covalent Binding Forces

Acid Dissociation Constant

Crystal engineering of novel pharmaceutical forms

Simon Grabowsky a * Technology Organisation, New Illawarra Road, Lucas Heights NSW 2234 Australia,

C. Slabbert and M. Rademeyer * Abstract

WITH NICOTINAMIDE AND ISONICOTINAMIDE

Chapter VII Introduction

organic papers Malonamide: an orthorhombic polymorph Comment

Supporting Information

research papers Automated assignment of graph-set descriptors for crystallographically symmetric molecules

Department of Chemistry, University of Basel, St. Johanns-Ring 19, Spitalstrasse 51, and Klingelbergstrasse 80, CH-4056 Basel, Switzerland

Weak hydrogen bonds in crystal engineering

organic papers Pamoic acid determined from powder diffraction data

Supporting Information

Acta Crystallographica. Section C: Crystal Structure Communications

CONTRIBUTION OF WEAK INTERMOLECULAR INTERACTIONS IN 3-ACETYL COUMARIN DERIVATIVES

Atomic and molecular interaction forces in biology

CHAPTER 8 REPORT ON HIGHER SHG EFFICIENCY IN BIS (CINNAMIC ACID): HEXAMINE COCRYSTAL

Physical Properties Explained (hopefully)

2. Acids and Bases. Grossman, CHE Definitions.

Stability and solid-state polymerization reactivity of imidazolyl- and benzimidazolyl-substituted diacetylenes: pivotal role of lattice water

A Journey from Data to Knowledge

Performing a Pharmacophore Search using CSD-CrossMiner

Supplementary Information for Evaluating the. energetic driving force for co-crystal formation

Version 1.2 October 2017 CSD v5.39

14: Organic Synthesis: Disconnection Approach. 17: Principles of molecular associations and organizations: Non-covalent synthesis

The Cambridge Structural Database (CSD) a Vital Resource for Structural Chemistry and Biology Stephen Maginn, CCDC, Cambridge, UK

Structure of Bis(isobutylammonium) Selenite and its Sesquihydrate

Hydrogen-Bond Acceptor Properties of Nitro-O Atoms: A Combined Crystallographic Database and Ab Initio Molecular Orbital Study

Crystal structures with a challenge: high-pressure crystallisation of ciprofloxacin sodium salts and their recovery to ambient pressure

Introduction to" Protein Structure

COCRYSTAL FORMATION OF PARACETAMOL WITH INDOMETHACIN AND MEFENAMIC ACID: AN EFFICIENT APPROACH TO ENHANCE SOLUBILITY

ACIDS AND BASES. Note: For most of the acid-base reactions, we will be using the Bronsted-Lowry definitions.

Polymorphism. 6 June 2012 Lecture 4 RUB

Analyzing Molecular Conformations Using the Cambridge Structural Database. Jason Cole Cambridge Crystallographic Data Centre

Chapter 6 Chemistry of Water; Chemistry in Water

Some properties of water

2.26 Intermolecular Forces

CHM Simple Lewis Structures (r14) Charles Taylor 1/5

Module 2 Acids and Bases. Lecture 3 Acids and Bases

3/30/2015. Third energy level. Second energy level. Energy absorbed. First energy level. Atomic nucleus. Energy released (as light)

To learn how to use molecular modeling software, a commonly used tool in the chemical and pharmaceutical industry.

100% ionic compounds do not exist but predominantly ionic compounds are formed when metals combine with non-metals.

Aqueous solutions. Solubility of different compounds in water

Department of Chemistry, Kansas State University, Manhattan, KS 66506, USA

Physical Chemistry Analyzing a Crystal Structure and the Diffraction Pattern Virginia B. Pett The College of Wooster

Investigation of Carbamazepine- Nicotinamide cocrystal solubility and dissolution by a UV imaging system. Ning Qiao. PhD Thesis

Chapter 16 Acid-Base Equilibria

The Crystal and Molecular Structures of Hydrazine Adducts with Isomeric Pyrazine Dicarboxylic Acids

HOMOLOGY MODELING. The sequence alignment and template structure are then used to produce a structural model of the target.

Supporting Information

New tetranuclear manganese clusters with [MnII3MnIII] and [MnII2MnIII2] metallic cores exhibiting the low and high spin ground state

Preformulation & Solid State Chemistry Services

Electronic Supplementary Information. Di(imino)aryltin(IV) dichlorides as tectons for heterometallic coordination compounds

CHEMISTRY. Module No and Title Module-, Electrophilic Aromatic Substitution: The ortho/para ipso attack, orientation in other ring systems.

Ab Initio Study of the Dimers of Nodifloridin B

Polymorphism from a Solution Perspective: Rationalisation at the Molecular Level

Spacer conformation in biologically active molecules*

Crystal Packing in vicinal Diols C n H m (OH) 2

AN AB INITIO STUDY OF INTERMOLECULAR INTERACTIONS OF GLYCINE, ALANINE AND VALINE DIPEPTIDE-FORMALDEHYDE DIMERS

Chapter-2 (Page 22-37) Physical and Chemical Properties of Water

Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner

Solids / Crystal Structure

Why Crystals Matter to the Real World

H O H. Chapter 3: Outline-2. Chapter 3: Outline-1

There are two types of bonding that exist between particles interparticle and intraparticle bonding.

Ab initio crystal structure determination of two polymorphic modifications of a local anesthetic agent, Tetracaine Hydrochloride

The exam time is 1hr45 minutes. Try to finish this practice exam in the same time.

Transcription:

Investigating crystal engineering principles using a data set of 50 pharmaceutical cocrystals Peter A. Wood, Cambridge Crystallographic Data Centre 24 th March 2009 ACS Spring Meeting, Salt Lake City, USA 1

Co-crystals The term co-crystal refers to a crystalline material that contains two or more neutral, organic molecules or a neutral molecule plus a salt In the context of pharmaceutical co-crystals, the molecule of most interest is the Active Pharmaceutical Ingredient (API) The additional molecule in a multi-component structure is referred to as the co-former 2

Co-crystals Co-crystals are slowly becoming more popular within the pharmaceutical industry Potentially greater flexibility and diversity than salts or hydrates To use co-crystals effectively, we need to understand & have some control over them A large family of co-crystals with a consistent host molecule is invaluable in learning about packing effects, motifs, H-bond competition and so on 3

Aims First multi-technique analysis of a large family of organic co-crystals Wanted to analyse structures using a range of methods to learn as much as possible Trying to avoid focussing solely on hydrogen bonds allow other features to show importance What can we learn about co-crystal design in general? 4

Carbamazepine Has anti-epileptic and analgesic properties Known to form at least four polymorphs Large family of multicomponent structures UK crystallography s favourite compound? Carbamazepine (CBZ) 5

Developing the dataset 37 structures retrieved from the CSD 13 new cocrystals determined through advanced co-crystal screening studies only carboxylic acid co-formers were screened In total, 50 CBZ structures Childs, Rodríguez-Hornedo et al. (2008) CrystEngComm, 10, 856-864. 6

Analytical tools New crystal form analysis tools in Materials module of the CSD visualiser (Mercury) arising from collaboration with Pfizer Institute for Pharmaceutical Materials Science: Hydrogen-bond motif analysis General packing feature analysis Crystal packing similarity analysis 7

Hydrogen-bond motif analysis Designed to provide search tools for interaction motifs Auto-generated sets of motifs Frequency of occurrence data (CSD) indicates how common or likely a motif is 37.7% 1.5% 22.3% 8

General packing feature analysis Easy selection of feature Simple searching to assess how unusual is this feature? & has this been seen before? Can relate structural features to stability 9

Packing similarity analysis Materials module similarity calculation Identifies clusters in common between crystal structures Can group structures based on level of geometric similarity 10

Aspects of analysis Start with description and analysis of hydrogen bonding interactions within the dataset The next talk (by Scott Childs, Renovo Research) will focus more on molecular shape-based packing features 11

Hydrogen bonding motifs Most obvious and well documented motif in CBZ structures is the carboxamide homodimer (a) occurs in all four polymorphs Carboxylic acid can provide competition the hetero-dimer (b) 12

Hydrogen bonding motifs Motif percentage frequencies observed in the CSD: Structures containing both groups Similar results seen in CBZ dataset for structures containing both groups (27% homo, 65% hetero) CBZ homo-dimer only perturbed by COOH group 33% 56% 3% 13

Hydrogen bonding motifs Can also use the motif analysis tools to investigate the more complicated motifs present In the analysis of co-crystals, the arrangement of the components in a motif is of interest Identified ring and chain patterns occurring as well as order of the groups interacting, i.e. CBZ or CF (coformer contact group) e.g. an infinite 2 molecule chain could be CBZ-CBZ-, CBZ-CF-, or CF-CF- 14

Rings R3 R4A R4B R6A R6B R6C R6D R6E 6 x x x 11 x 16 x x 17 x x x 18 x 19 x 20 x 21 x 23 x x x 24 x x 27 x x x 28 x x x 30 x 31 x x x x 38 x 43 x 45 x 50 x CBZ-CF-CBZ-CF- CBZ-CF- CBZ-CF-CBZ-CBZ- CF-CBZ- CBZ-CBZ-CF-CF- CBZ-CF-CBZ-CBZ- CF-CF- CBZ-CF-CF-CBZ-CF- CF- CBZ-CBZ-CF-CF-CF- CF- CBZ-CF-CBZ-CF- CBZ-CBZ-CF- 15 Hydrogen bonding motifs C1A C1B C2A C2B C3A C3B Infinite Chains 6 x x 8 x Motifs: 9 x 17 x x 21 x 23 x 24 x 27 x x Intermolecular CBZ CBZ contacts are not common 28 x x 32 x 37 x 38 x 39 x x 43 x 50 x CBZ-CBZ-CF- CF-CF-CBZ- CF-CBZ- CF-CF- CF-CF- CBZ-CBZ-

Hydrogen bonding motifs Role of co-former as a link: 16

Hydrogen bonding motifs Dimensionality: H-bond dimension # of structures % of structures Ave. # of Donors Ave. # of Acceptors 0D 17 42.5 0.8 1.5 1D 11 27.5 1 1.8 2D 7 17.5 2.6 2.1 3D 5 12.5 2.8 2.6 Preference for discrete aggregates High correlation between dimension of H-bonding network & average number of acceptors 17

Hydrogen bonding Lack of acceptor for second carboxamide N-H Structure 36 CBZ/benzoic acid (1:1) 18

Etter s first rule Etter s rules: How many CBZ structures violate the first rule? Is this unusual? Why does it happen? 19

Etter s first rule Start with evaluation of the CSD to get a broad perspective first How do you define a hydrogen bond? Selected very broad limits Q A H Q B [where Q A = N,O & Q B = N, O, S, F, Cl, Br, I] Contact defined as within sum of vdw radii + 0.3 Å 20

Etter s first rule Transformed variables to: normalise distances use spherical coordinates, solving angle bias problems Lommerse et al. (1996) JACS, 118, 3108-3116. 21

Etter s first rule Clear peak at θ = 180 Smaller peaks at 130 and 105 due to intramolecular contacts Peak finishes before x = 1 22

Etter s first rule 97.5% of strong hydrogen-bond donor hydrogen atoms have an acceptor within sum of vdw plus 0.3 Å with D-H A angle 90 In the CBZ dataset, 12 of the structures (24%) do not have such an acceptor Appears likely to be due to steric hindrance 23

Conclusions Developed a dataset of 50 structures containing the same pharmaceutically-relevant compound Applying newly developed analytical tools to learn more about co-crystal design Motif competition with the carboxamide dimer only seen to be successful using carboxylic acids Etter s first rule broken for 24% of the dataset indication that molecular shape is crucial 24

Acknowledgements Scott Childs (formerly with SSCI/Aptuit, now CEO of Renovo Research) Naír Rodríguez-Hornedo & L. Sreenivas Reddy (University of Michigan) Kenneth Hardcastle (Emory University) CCDC Elna Pidcock László Fábián James Chisholm Clare Macrae Funding: 25